Raymond James & Associates G1 Therapeutics, Inc. Transaction History

Raymond James & Associates

$146 Billion
Q1 2024

A detailed history of Raymond James & Associates transactions in G1 Therapeutics, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 802,835 shares of GTHX stock, worth $1.83 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

802,835

Previous 565,555 41.96%

Holding current value

$1.83 Million

Previous $1.72 Million 101.16%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	BUY	$2.1 - $4.83 $498,288 - $1.15 Million	237,280 Added 41.96%	802,835 $3.47 Million
Q4 2023 Jan 16, 2024	SELL	$1.12 - $3.73 $403,447 - $1.34 Million	-360,221 Reduced 38.91%	565,555 $1.72 Million
Q3 2023 Oct 24, 2023	BUY	$1.22 - $2.67 $163,067 - $356,877	133,662 Added 16.87%	925,776 $1.33 Million
Q2 2023 Jul 25, 2023	BUY	$2.46 - $3.14 $109,969 - $140,367	44,703 Added 5.98%	792,114 $1.97 Million
Q1 2023 Apr 14, 2023	BUY	$2.57 - $8.16 $638,665 - $2.03 Million	248,508 Added 49.81%	747,411 $2 Million

Q4 2022 Feb 08, 2023	BUY	$5.19 - $13.5 $100,000 - $260,118	19,268 Added 4.02%	498,903 $2.71 Million
Q3 2022 Oct 25, 2022	BUY	$5.17 - $16.99 $214,446 - $704,728	41,479 Added 9.47%	479,635 $5.99 Million
Q2 2022 Aug 12, 2022	BUY	$4.04 - $8.51 $162,719 - $342,757	40,277 Added 10.12%	438,156 $2.16 Million
Q1 2022 May 11, 2022	BUY	$7.6 - $11.02 $1.27 Million - $1.84 Million	166,564 Added 72.01%	397,879 $3.02 Million
Q4 2021 Feb 08, 2022	BUY	$10.16 - $16.17 $981,212 - $1.56 Million	96,576 Added 71.68%	231,315 $2.36 Million
Q3 2021 Nov 02, 2021	BUY	$13.16 - $22.47 $27,517 - $46,984	2,091 Added 1.58%	134,739 $1.81 Million
Q2 2021 Aug 11, 2021	BUY	$19.57 - $26.32 $247,129 - $332,368	12,628 Added 10.52%	132,648 $2.91 Million
Q1 2021 May 14, 2021	SELL	$17.58 - $32.59 $438,322 - $812,566	-24,933 Reduced 17.2%	120,020 $2.89 Million
Q4 2020 Feb 12, 2021	SELL	$10.99 - $20.4 $215,008 - $399,105	-19,564 Reduced 11.89%	144,953 $2.61 Million
Q3 2020 Nov 04, 2020	BUY	$11.55 - $23.75 $135,469 - $278,563	11,729 Added 7.68%	164,517 $1.9 Million
Q2 2020 Jul 28, 2020	BUY	$9.57 - $24.37 $1.35 Million - $3.45 Million	141,503 Added 1253.9%	152,788 $3.71 Million
Q1 2020 Apr 21, 2020	BUY	$9.07 - $26.32 $22,366 - $64,905	2,466 Added 27.96%	11,285 $124,000
Q4 2019 Feb 12, 2020	BUY	$20.54 - $31.0 $181,142 - $273,389	8,819 New	8,819 $233,000

Others Institutions Holding GTHX

# of Institutions

Shares Held

14.7M

Call Options Held

631K

Put Options Held

347K

View Full List

About G1 Therapeutics, Inc.

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $97.5M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

More about GTHX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates G1 Therapeutics, Inc. Transaction History